Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial
Conditions
- Chronic Intestinal Pseudo-obstruction
Interventions
- DRUG: Rifaximin oral tablet
- DRUG: Placebo oral tablet
Sponsor
Yokohama City University
Collaborators